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Abstract: Carbon nanotubes (CNTs) are promising nanomaterials having unique physical 
and chemical properties, with applications in a variety of fields. In this review, we briefly 
summarize the intrinsic properties of highly purified multi-walled CNTs (MWCNTs, 
HTT2800) and their potential hazardous effects on intracellular and extracellular pathways, 
which alter cellular signaling and impact major cell functions such as differentiation,  
reactive oxygen species (ROS) production, apoptosis, and autophagy. A recent study 
suggested that the induction of autophagy by CNTs causes nanotoxicity. Autophagy was 
recently recognized as a critical cell death pathway, and autophagosome accumulation has 
been found to be associated with exposure to CNTs. Although autophagy is considered as  
a cytoprotective process, it is often observed in association with cell death, and the 
relationship between autophagy and cell death remains unclear. Our recent study suggests 
that the levels of autophagy-related genes (LC3B) and autophagosome formation are clearly 
up-regulated, along with an increase in numbers of autophagosome vacuoles. This review 
highlights the importance of autophagy as an emerging mechanism of CNT toxicity. 
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1. Introduction 
Carbon nanotubes (CNTs) have been functionalized to improve their biocompatibility and to promote 
their interaction with biomolecules [1–4]. The discovery of CNTs has resulted in significant advances 
in medicine owing to their unique structure and properties [4,5]. This includes applications such as 
cellular drug delivery systems and biochemical markers [4–6]. In vitro toxicology studies have attempted 
to link CNTs with acute and chronic cellular responses. Several investigations of acute toxicity and 
pathogenicity of CNTs in cellular and animal models have been conducted. To date, documented 
physiological changes in cells exposed to CNTs include inflammation [7], apoptosis [8], reactive oxygen 
species (ROS)-related responses [4,9], and cell differentiation. Previous reports suggest that the hazard 
risk associated with the use of CNTs is strongly dependent on the relative amount of iron catalyst [4]. 
However, the mechanism underlying the chronic toxicity caused by multi-walled CNTs (MWCNTs), 
especially the adverse effects in humans, is relatively unclear. Recent in vivo studies have shown that 
dispersed MWCNTs induce interstitial lung fibrosis without causing persistent lung inflammation after 
several weeks of exposure [10,11]. These reports suggest that MWCNTs induce pulmonary fibrotic 
response by directly stimulating lung fibrosis. Furthermore, a recent study suggested that CNTs are 
emerging as a novel class of autophagy inducers [12]. Autophagy, which was first identified in 1963, is 
a tightly regulated cellular process that maintains homeostasis [13,14]. Common to nearly all eukaryotes, 
autophagy is a catabolic process in which intracellular degradation of dysfunctional cellular components 
or invaders occurs within lysosomes [15]. Recently, a variety of nanomaterials have been reported to 
induce autophagy [16–18]. Additionally, autophagy plays an important role in some human diseases, 
including lung disease, cancer, neurodegenerative disorders, and viral infections [19]. 
2. CNT Cytotoxicity and Impurities 
CNTs have a small aerodynamic diameter and can easily penetrate lung tissue [20]. Several 
mechanisms of lung disease caused by CNTs have been proposed; one hypothesis is that they act as 
oxidative stimuli and promote inflammation and DNA damage [21–23]. The most important factors 
suggested to cause CNT-mediated toxicity are the impurities, especially catalytic metal contaminants 
produced during the preparation and purification processes [24,25]. However, it has been also reported 
that the presence of metal impurities can cause confusion related to cell toxicity and the resulting health 
risks associated with use of CNTs. Iron and reactive oxygen species (ROS) are being increasingly 
recognized as important mediators of cell death [26]. ROS are chemically reactive oxygen-containing 
molecules that are formed as byproducts during normal metabolism of oxygen. The resulting oxidative 
damage due to ROS causes damage to DNA, proteins, and lipids and the activation of cell signaling 
pathways [4,27]. Our previous study focused on the acute toxicity of a vapor-grown CNT, HTT2800, 
which is a highly purified MWCNT that was prepared using high-temperature treatment [22,28]. Shape 
of HTT2800 is characterized by a high aspect ratio, a diameter of 100 to 150 nm, and a length of 10 to 
20 µm [28]. Since the iron catalyst was removed from HTT2800 in an argon atmosphere, only a very 
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low concentration (<20 ppm) of the iron-based material remained [4]. As expected, quantification of 
ROS produced with exposure to HTT2800 (up to 30 μg/mL) revealed no indication of oxidative  
stress [4]. This result suggests that the potential hazard risk associated with the use of CNTs is strongly 
dependent on its iron catalyst content [4]. However, our previous study also indicated that exposure of  
a human bronchial epithelial cell line (BEAS-2B) to HTT2800 resulted in the release of inflammatory 
mediators [4]. The production of the proinflammatory cytokines interleukin (IL)-6 and IL-8, an 
indication of an inflammatory response, increased following HTT2800 exposure [4]. Damage to the 
bronchial epithelium is often observed in patients with asthma and other allergic diseases of the airways. 
IL-6 is linked to allergic responses involving asthma [29], while IL-8 is associated with chronic 
obstructive pulmonary disease [30,31]. Furthermore, several in vitro studies have been performed to 
evaluate the biological effects of HTT2800. In general, programmed cell death can be classified  
into three main groups: apoptosis, necrosis, and autophagy. HTT2800 exposure in BEAS-2B cells 
produced a concentration-dependent cytotoxic response, lactate dehydrogenase (LDH) leakage, and 
DNA damage [4]. The viability of HTT2800-exposed cells was significantly decreased, and the  
LDH-leakage rate was increased in a dose-dependent manner [4]. In addition, accumulation of HTT2800 
was observed around the nucleus; a balloon-like nuclear morphology, which is typically associated with 
necrotic cell death, was also observed. Cell apoptosis is also commonly evaluated using a caspase-3 
activation assay. Indeed, caspase-3 activation correlated with internucleosomal DNA fragmentation  
of the BEAS-2B cells; however, HTT2800 did not induce common apoptotic fragmentation of  
caspase-3 [4]. Furthermore, a caspase-3 inhibitor, z-VAD-FMK, failed to suppress HTT2800-induced 
cell death [18]. This result further supports the idea that HTT2800 triggered the necrotic effects observed 
in BEAS-2B cells. These results also suggest that HTT2800 induced the loss of cell membrane integrity 
as well as enhanced DNA damage and cell toxicity. Taken together, our results imply that the highly 
purified CNT, HTT2800, was prepared at an adequate concentration to induce acute toxicity. 
3. Intracellular Uptake of CNT and the Underlying Mechanism  
Although the mechanism of cellular uptake of CNTs may differ depending on its formulation and 
size, the pathways by which CNTs enter cells and their subsequent intracellular trafficking and 
distribution remain poorly understood. In general, there are three ways by which CNTs can enter a cell: 
endocytosis, phagocytosis, and diffusion [32,33]. Endocytosis is an essential cellular process that allows 
for the maintenance of cellular homeostasis and the uptake of substances [34]. Endocytic pathways have 
been divided into two types: the internalization of large substances (>0.5 μm), termed “phagocytosis”, 
and the uptake of fluids and small substances and molecules, termed “pinocytosis” [35]. Phagocytosis, 
involving vesicular internalization of particulate matter such as bacteria, is an active and highly regulated 
process that involves specific plasma membrane-surface receptors and a signaling cascade [36]. 
Phagocytosis of CNTs by macrophages depends on the size, solubility, surface charge, and formulation 
of the CNTs [37] and the macromolecules are internalized into intracellular compartments [38]. These 
processes are energy-dependent and are impaired at low temperatures and in low ATP environments [39]. 
On the other hand, diffusion is an energy-independent, passive process by which the CNTs can diffuse 
through the cellular membrane. Our previous study indicated that HTT2800 was internalized into  
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BEAS-2B cells [4]. Interestingly, after staining the cell nuclei, accumulation of HTT2800 was observed 
around the nucleus.  
However, despite evidence of HTT2800 uptake into human lung cells and the central role of these 
cells in HTT2800-induced lung disease, a limited amount of data is currently available to determine the 
fate of HTT2800 once inside BEAS-2B cells.  
4. CNT and Autophagy or Autophagic Cell Death  
Autophagosome accumulation induced by CNT treatment was found to be associated with cell death 
in a majority of published reports [40]. However, the possibility of autophagy inhibition has not been 
adequately investigated. We recently reported that HTT2800 has emerged as a novel class of autophagy 
inducers [18]. Autophagy is a tightly regulated cellular process involving bulk cytoplasmic and organelle 
degradation [41–43]. Common to nearly all eukaryotes, autophagy is a lysosomal degradation pathway 
that recycles intracellular components such as protein aggregates and damaged or dysfunctional 
intracellular organelles [41]. CNTs have been detected in lysosomes upon internalization, and they have 
been found to be associated with lysosomal dysfunction [33]. Autophagy was recently recognized as a 
critical cell death pathway and autophagosome accumulation was found to be associated with exposure 
to various nanoparticles [17,44]. In eukaryotes, autophagy is the main catabolic mechanism by which 
the cell degrades cytoplasmic components that are engulfed in double membrane-bound vesicles known 
as autophagosomes [43]. In the first step of autophagosome development, the cytoplasmic particulate 
matter is sequestered and then the double-membrane autophagosome fuses with a lysosome to form the 
autolysosome. To date, three forms of autophagy have been identified: (1) chaperone-mediated autophagy; 
(2) microautophagy; and (3) macroautophagy, which differ in the mode of delivery to the lysosome [45]. 
Our recent study suggested that HTT2800-induced autophagy in BEAS-2B cells was based on expression 
of the autophagic marker, light-chain 3 (LC3) and its effect on cell death and proliferation [18]. This 
characteristic conversion of LC3 can be used to monitor autophagic activity. LC3 was originally 
identified as a subunit of microtubule-associated proteins 1A and 1B [46], which associated with  
the autophagosome membranes after processing. Cleavage of LC3 at the carboxyl terminus occurs 
immediately following synthesis of the cytosolic form of non-lipidated LC3B-I (19 kDa). During 
autophagy, LC3-I is converted to lipidated LC3B-II (16 kDa), which is tightly bound to the  
membrane [46]. HTT2800 significantly induced LC3B-II expression, which decreased after treatment 
with an autophagy inhibitor, 3-methyladenine (3-MA) [18]. Furthermore, we monitored the cellular 
distribution of green fluorescent protein-tagged LC3B using fluorescence microscopy. We found that in 
contrast to the cytoplasmic localization of LC-3B-I, LC3-BII associated with both the outer and inner 
membranes of the autophagosome and the number of vacuoles was significantly lower in untreated cells 
than in HTT2800-treated human lung cells [18]. We further examined whether endocytosis and lysosomal 
regulation might be involved in HTT2800-induced cell death. Prior to HTT2800 exposure, we treated cells 
with brefeldin A, which inhibits the transport of proteins from the endoplasmic reticulum to the Golgi;  
3-MA, which inhibits autophagosome formation; or E64-d and pepstatin A (E64-d + pepstatin A), which 
are lysosomal proteinase inhibitors. Interestingly, 3-MA and E64-d + pepstatin A, but not brefeldin A, 
provided protection against the HTT2800-induced cell death that occurred via the autophagic rather than 
the endocytic pathway [18]. In addition, pretreatment with the caspase inhibitor, z-VAD-FMK, had no 
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significant protective effect on HTT2800-induced inhibition of cell growth. Interestingly, we found that 
caspase-3 activation was induced in 3-MA-treated BEAS-2B cells [18]. It is also possible that CNTs 
induce autophagy via an oxidative stress and inflammatory response, such as accumulation of damaged 
proteins due to a decrease in autophagy flux. It has been reported that the disruption of autophagy flux 
could lead to enhanced NLRP3 inflammasome accumulation and exaggerated IL-1b production leading 
to lung fibrosis [47]. These results suggested that autophagy modulation mediated by CNTs may lead to 
autophagy-mediated cell death and could serve as a specific signal for lung diseases. In conclusion, these 
studies taken together, suggest that autophagy plays a functional role in the stress response to CNT 
exposure in vitro, and that CNTs might also contribute to autophagic cell death (Figure 1). These markers 
could serve as possible therapeutic targets that could be explored further in the clinical management of 
lung diseases. 
 
Figure 1. Carbon nanotubes (CNT)-induced autophagy. Schematic representation of the 
proposed mechanism for HTT2800. During autophagy, a double-layered, membrane-bound 
autophagosome is formed that surrounds the proteins and damaged organelles identified  
for degradation. When autophagy is blocked by 3-MA, caspase-3 activation is induced. 
Autophagy inhibition accelerates apoptosis in cells. Furthermore, HTT2800-induced 
autophagic cell death occurred in the absence of caspase activation, via an ROS-independent 
pathway. These results suggest that HTT2800 predominantly causes autophagy rather than 

























Cellular and molecular findings suggest that HTT2800 might be associated with compromised 
respiratory systems. However, the detailed mechanism of CNT-induced autophagy accumulation in 
many cases remains unclear. Further studies are needed to elucidate the molecular mechanism 
underlying the interaction between CNTs and the autophagy machinery. A better-designed prospective 
study of specific HTT2800-mediated cell regulation would help clarify the mechanisms underlying the 
link between HTT2800 and cell function. 
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